MedTrace Logo

Heparin-Binding Protein and Heparins

NCT04146493 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-11-18

No results posted yet for this study

Summary

Heparin-Binding protein is a protein from primary and secretory granluae of white blood cells. It is released when white blood cells become activated and has been advocated as a biomarker for sepsis. The aim of this study is to find out if Heparins in clinical doses can change the level of Heparin-binding protein in plasma.

Conditions

Interventions

DIAGNOSTIC_TEST

Blood samples for Heparin-binding protein measurement

Blood samples before and after given heparin

Sponsors & Collaborators

Principal Investigators

  • Halla Halldorsdottir, MD · Karolinska Institutet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2021-11-30
Completion
2021-11-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04146493 on ClinicalTrials.gov